SOUTH PLAINFIELD, N.J. (AP) — SOUTH PLAINFIELD, N.J. (AP) — PTC Therapeutics Inc. (PTCT) on Thursday reported a loss of $91.6 million in its first quarter.
The South Plainfield, New Jersey-based company said it had a loss of $1.20 per share.
The results exceeded Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of $1.21 per share.
The biopharmaceutical company posted revenue of $210.1 million in the period, also surpassing Street forecasts. Five analysts surveyed by Zacks expected $160.3 million.
PTC Therapeutics expects full-year revenue in the range of $600 million to $680 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTCT at https://www.zacks.com/ap/PTCT
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
